Funder: Ionis Pharmaceuticals
Due Dates: Rolling (submit at least 60 days before program/event start date)
Funding Amounts: No specified minimum or maximum; award size and duration vary by proposal and available resources.
Summary: Supports independent, unbiased medical education initiatives advancing clinical care in hereditary angioedema and severe hypertriglyceridemia.
Key Information: Only accredited organizations (not individuals or private practice groups) are eligible; all content must be independent of Ionis influence.